NCT06818058View on ClinicalTrials.gov

TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 30, 2026

Conditions
EGFR Inhibitor-associated Rash
Interventions
DRUG

Brimonidine tartrate Gel

Once daily applications for 7 days

DRUG

Placebo gel (no Brimonidine tartrate)

Once daily applications for 7 days

Trial Locations (3)

13273

RECRUITING

Institut Paoli Calmette, Marseille

69008

RECRUITING

Hopital Privé Jean Mermoz, Lyon

06189

NOT_YET_RECRUITING

Centre Antoine Lacassagne, Nice

All Listed Sponsors
lead

Tarian Pharma

INDUSTRY